Volume 84, Issue 5, Pages (November 2013)

Slides:

Advertisements

Similar presentations

Vitamin D levels and patient outcome in chronic kidney disease

Advertisements

Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients Maurizio Postorino, Carmen.

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 87, Issue 5, Pages (May 2015)

Volume 81, Issue 12, Pages (June 2012)

Volume 86, Issue 3, Pages (September 2014)

The risk of hospitalization and modality failure with home dialysis

John P. Middleton, Patrick H. Pun Kidney International

Volume 74, Issue 12, Pages (December 2008)

Volume 87, Issue 1, Pages (January 2015)

Volume 88, Issue 2, Pages (August 2015)

Carmine Zoccali, David Goldsmith, Rajiv Agarwal, Peter J

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 88, Issue 5, Pages (November 2015)

Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? Kitty J. Jager, Bengt Lindholm, David Goldsmith, Danilo Fliser,

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 80, Issue 9, Pages (November 2011)

Volume 81, Issue 11, Pages (June 2012)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 79, Issue 9, Pages (May 2011)

U-shaped effect of eGFR and mortality

Constance E. Ruhl, James E. Everhart Gastroenterology

Volume 74, Issue 8, Pages (October 2008)

The analysis of survival data: the Kaplan–Meier method

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular.

Body size and outcomes on peritoneal dialysis in the United States

Volume 83, Issue 4, Pages (April 2013)

Volume 73, Issue 12, Pages (June 2008)

Vitamin D levels and patient outcome in chronic kidney disease

The lingering dilemma of arterial pressure in CKD: what do we know, where do we go? Rajiv Agarwal, Alberto Martinez-Castelao, Andrzej Wiecek, Ziad Massy,

Peter J. Blankestijn, Gerard London, Danilo Fliser, Kitty J

Does reducing salt intake increase cardiovascular mortality?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Alternate-day dialysis may be needed for hemodialysis patients

Methods for guideline development

Volume 84, Issue 5, Pages (November 2013)

Volume 76, Issue 9, Pages (November 2009)

Nephrology Crossword: Glomerulonephritis

Volume 80, Issue 6, Pages (September 2011)

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease C.P. Kovesdy, S. Ahmadzadeh,

Volume 85, Issue 5, Pages (May 2014)

Volume 73, Issue 8, Pages (April 2008)

Volume 82, Issue 9, Pages (November 2012)

Volume 74, Issue 8, Pages (October 2008)

Carmine Zoccali, Francesca Mallamaci Kidney International

Organ transplantation goes to the movies

Volume 83, Issue 5, Pages (May 2013)

Volume 72, Issue 2, Pages (July 2007)

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Volume 72, Issue 7, Pages (October 2007)

Cardiovascular risk in chronic kidney disease

Volume 75, Issue 1, Pages (January 2009)

Renal replacement therapy in Latin America

Importance of blood pressure control in hemodialysis patient survival

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 75, Issue 7, Pages (April 2009)

Volume 76, Issue 1, Pages (July 2009)

Antioxidant therapy in hemodialysis patients: a systematic review

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients M.R. Marshall, B.G. Byrne, P.G. Kerr,

Increase of physical activity over time associated with lower HF risk

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

Sugar-sweetened beverages and chronic disease

Volume 83, Issue 3, Pages (March 2013)

Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease

Presentation transcript:

Volume 84, Issue 5, Pages 998-1008 (November 2013) Use of phosphate-binding agents is associated with a lower risk of mortality Jorge B. Cannata-Andía, José L. Fernández-Martín, Francesco Locatelli, Gérard London, José L. Gorriz, Jürgen Floege, Markus Ketteler, Aníbal Ferreira, Adrian Covic, Boleslaw Rutkowski, Dimitrios Memmos, Willem-Jan Bos, Vladimir Teplan, Judit Nagy, Christian Tielemans, Dierik Verbeelen, David Goldsmith, Reinhard Kramar, Pierre-Yves Martin, Rudolf P. Wüthrich, Drasko Pavlovic, Miha Benedik, José Emilio Sánchez, Pablo Martínez-Camblor, Manuel Naves-Díaz, Juan J. Carrero, Carmine Zoccali Kidney International Volume 84, Issue 5, Pages 998-1008 (November 2013) DOI: 10.1038/ki.2013.185 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Hazard ratios of unadjusted relative all-cause and cardiovascular mortality in different subgroups of patients prescribed or not prescribed phosphate-binding agents (PBAs). CV, cardiovascular; CVD, cardiovascular disease. Kidney International 2013 84, 998-1008DOI: (10.1038/ki.2013.185) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Relative all-cause and cardiovascular mortality in patients prescribed different types of phosphate-binding agents (PBAs). Unadjusted (univariate) and after adjustments with the three multivariate models used. HR, hazard ratio. Kidney International 2013 84, 998-1008DOI: (10.1038/ki.2013.185) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Relative all-cause mortality in patients prescribed the most currently used phosphate-binding agents (PBAs) excluding those labeled as ‘others’. Unadjusted (univariate) and after adjustments with the three multivariate models used. CI, confidence interval; HR, hazard ratio. Kidney International 2013 84, 998-1008DOI: (10.1038/ki.2013.185) Copyright © 2013 International Society of Nephrology Terms and Conditions